Exploring antidiabetic drug targets as potential disease-modifying agents in osteoarthritisResearch in context

Summary: Background: Osteoarthritis is a leading cause of disability, and disease-modifying osteoarthritis drugs (DMOADs) could represent a pivotal advancement in treatment. Identifying the potential of antidiabetic medications as DMOADs could impact patient care significantly. Methods: We designed...

Full description

Bibliographic Details

Published in:	EBioMedicine
Main Authors:	Kai Fu, Shucheng Si, Xinzhong Jin, Yan Zhang, Vicky Duong, Qianying Cai, Guangyi Li, Win Min Oo, Xianyou Zheng, Cindy G. Boer, Yuqing Zhang, Xiaojuan Wei, Changqing Zhang, Youshui Gao, David J. Hunter
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Osteoarthritis Drug targets Antidiabetic drugs Gene expression Mendelian randomization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396424003219